Item 8.01 Other Events.
On March 8, 2021, Talis Biomedical Corporation (the "Company") issued a press
release titled "Talis Provides Update on Regulatory Pathway for Emergency Use
Authorization (EUA) of its Talis One™ COVID-19 Test." A copy of the Company's
press release is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press Release dated March 8, 2021
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses